Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.
Also called NCT03037047
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 320 participants
- Sponsor
- Green Valley Group of China
- Registry
-
NCT03037047
-
- Other papers using this trial's data
- A Prospective Randomized Multicenter Controlled Trial on Salvianolate for Treatment of Unstable Angina Pectoris in A Chinese Elderly Population
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03037047. Randomized; quadruple masking; primary purpose treatment. Start 2016-05-11 (actual); primary completion 2017-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
- Condition
- Unstable Angina
- Intervention (Drug)
- 0.9% Sodium Chloride Injection
- Intervention (Drug)
- salvianolate injection
- Lead sponsor
- Green Valley Group of China
Record details
- Record id
cardio:ct-nct03037047- Content hash
14c9e9097c5553b8663624fad5bca04e47b3f9c4271fa6865e0afb609272a0e4